PAVmed to Hold Business Update Conference Call on November 21, 2019
November 06, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization
November 05, 2019 07:00 ET
|
PAVmed Inc.
Extends cash runway to support multiple milestones including commercialization of two lead products NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or...
PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update
September 05, 2019 09:30 ET
|
PAVmed Inc.
Conference call to be held on September 5, 2019 at 4:30 p.m. Eastern time NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
USPTO Grants PAVmed Patent Covering its CarpX™ Device
August 21, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the U.S....
PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission
August 15, 2019 09:30 ET
|
PAVmed Inc.
All 20 patients underwent successful CarpX procedures while passing primary effectiveness endpoint, with all follow-up patients to date passing primary safety endpoint NEW YORK, Aug. 15, 2019 ...
PAVmed to Hold Business Update Conference Call on September 5, 2019
August 07, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed to Join Russell Microcap® Index
June 26, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the Company...
PAVmed Subsidiary Lucid Diagnostics Receives FDA 510(k) Clearance for EsoCheck™
June 24, 2019 10:46 ET
|
PAVmed Inc.
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product medical device company, today announced that its...
PAVmed Reports First Quarter 2019 Financial Results and Provides Business Update
May 21, 2019 09:30 ET
|
PAVmed Inc.
Conference call to be held on May 21, 2019 at 4:30 p.m. Eastern time NEW YORK, May 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVmed Announces First Human CarpX™ Procedures
May 20, 2019 09:30 ET
|
PAVmed Inc.
First nine patients undergo successful CarpX procedures as part of FIH clinical safety study NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or...